Enhanced cancer immunotherapy by microneedle patch-assisted delivery
US11896800B2 · kind B2 · utility
0Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 1, 2017 |
| Grant date | Feb 13, 2024 |
| Priority date | — |
| Expiry date | Apr 23, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2037/0061
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are self-degradable microneedle devices for the controlled-release of an immunotherapeutic agent. Also disclosed are methods for treating a disease (for example, cancer) using a self-degradable microneedle patch for the sustained delivery of an immunotherapeutic agent (for example, a PD1 antibody).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.